These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33039564)

  • 21. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, crystal structure and biological evaluation of substituted quinazolinone benzoates as novel antituberculosis agents targeting acetohydroxyacid synthase.
    Lu W; Baig IA; Sun HJ; Cui CJ; Guo R; Jung IP; Wang D; Dong M; Yoon MY; Wang JG
    Eur J Med Chem; 2015 Apr; 94():298-305. PubMed ID: 25771108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of hydrazone containing thiadiazoles as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
    Doğan H; Doğan ŞD; Gündüz MG; Krishna VS; Lherbet C; Sriram D; Şahin O; Sarıpınar E
    Eur J Med Chem; 2020 Feb; 188():112035. PubMed ID: 31951850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computational, crystallographic studies, cytotoxicity and anti-tubercular activity of substituted 7-methoxy-indolizine analogues.
    Venugopala KN; Chandrashekharappa S; Pillay M; Abdallah HH; Mahomoodally FM; Bhandary S; Chopra D; Attimarad M; Aldhubiab BE; Nair AB; Sreeharsha N; Morsy MA; Pottathil S; Venugopala R; Odhav B; Mlisana K
    PLoS One; 2019; 14(6):e0217270. PubMed ID: 31163040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of carbohydrazides and carboxamides as anti-tubercular agents.
    Kumar G; Krishna VS; Sriram D; Jachak SM
    Eur J Med Chem; 2018 Aug; 156():871-884. PubMed ID: 30056283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and Structural Elucidation of Novel Benzothiazole Derivatives as Anti-tubercular Agents: In-silico Screening for Possible Target Identification.
    Venugopala KN; Chandrashekharappa S; Pillay M; Bhandary S; Kandeel M; Mahomoodally FM; Morsy MA; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K; Odhav B
    Med Chem; 2019; 15(3):311-326. PubMed ID: 29968540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indole chalcones: Design, synthesis, in vitro and in silico evaluation against Mycobacterium tuberculosis.
    Ramesh D; Joji A; Vijayakumar BG; Sethumadhavan A; Mani M; Kannan T
    Eur J Med Chem; 2020 Jul; 198():112358. PubMed ID: 32361610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel isoniazid embedded triazole derivatives: Synthesis, antitubercular and antimicrobial activity evaluation.
    Patil PS; Kasare SL; Haval NB; Khedkar VM; Dixit PP; Rekha EM; Sriram D; Haval KP
    Bioorg Med Chem Lett; 2020 Oct; 30(19):127434. PubMed ID: 32717369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In Silico and in Vitro Studies of Fluorinated Chroman-2-Carboxilic Acid Derivatives as an Anti-tubercular Agent.
    Kapadiya KM; Jadeja YS; Banik A; Khunt RC
    Folia Med (Plovdiv); 2018 Dec; 60(4):601-609. PubMed ID: 31188774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-based design, synthesis and biological evaluation of a newer series of pyrazolo[1,5-a]pyrimidine analogues as potential anti-tubercular agents.
    Modi P; Patel S; Chhabria M
    Bioorg Chem; 2019 Jun; 87():240-251. PubMed ID: 30908967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel fatty acid-thiadiazole derivatives as potential antimycobacterial agents.
    Mali JK; Sutar YB; Pahelkar AR; Verma PM; Telvekar VN
    Chem Biol Drug Des; 2020 Jan; 95(1):174-181. PubMed ID: 31581353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of 1,2,3-triazole based quinoxaline-1,4-di-N-oxide derivatives as potential anti-tubercular agents.
    Srinivasarao S; Nandikolla A; Suresh A; Ewa AK; Głogowska A; Ghosh B; Kumar BK; Murugesan S; Pulya S; Aggarwal H; Sekhar KVGC
    Bioorg Chem; 2020 Jul; 100():103955. PubMed ID: 32464405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bis-spirochromanones as potent inhibitors of Mycobacterium tuberculosis: synthesis and biological evaluation.
    Dongamanti A; Aamate VK; Devulapally MG; Gundu S; Balabadra S; Manga V; Yogeeswari P; Sriram D; Balasubramanian S
    Mol Divers; 2017 Nov; 21(4):999-1010. PubMed ID: 28840414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New one-pot synthesis of anti-tuberculosis compounds inspired on isoniazid.
    Ghiano DG; Recio-Balsells A; Bortolotti A; Defelipe LA; Turjanski A; Morbidoni HR; Labadie GR
    Eur J Med Chem; 2020 Dec; 208():112699. PubMed ID: 32927391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of cationic fullerene quinazolinone conjugates and their binding mode with modeled Mycobacterium tuberculosis hypoxanthine-guanine phosphoribosyltransferase enzyme.
    Patel MB; Kumar SP; Valand NN; Jasrai YT; Menon SK
    J Mol Model; 2013 Aug; 19(8):3201-17. PubMed ID: 23625031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, In silico Molecular Docking and Pharmacokinetic Studies, In vitro Antimycobacterial and Antimicrobial Studies of New Imidozolones Clubbed with Thiazolidinedione.
    Khan IH; Patel NB; Patel VM
    Curr Comput Aided Drug Des; 2018; 14(4):269-283. PubMed ID: 29766819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel pyrazine based anti-tubercular agents: Design, synthesis, biological evaluation and in silico studies.
    Hassan NW; Saudi MN; Abdel-Ghany YS; Ismail A; Elzahhar PA; Sriram D; Nassra R; Abdel-Aziz MM; El-Hawash SA
    Bioorg Chem; 2020 Mar; 96():103610. PubMed ID: 32028062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Andrographolide: A potent antituberculosis compound that targets Aminoglycoside 2'-N-acetyltransferase in Mycobacterium tuberculosis.
    Prabu A; Hassan S; Prabuseenivasan ; Shainaba AS; Hanna LE; Kumar V
    J Mol Graph Model; 2015 Sep; 61():133-40. PubMed ID: 26245695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation, biological evaluation and molecular docking study of imidazolyl dihydropyrimidines as potential Mycobacterium tuberculosis dihydrofolate reductase inhibitors.
    Desai NC; Trivedi AR; Khedkar VM
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4030-5. PubMed ID: 27397497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.